tetraethylammonium has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eadie, L; Hughes, TP; White, DL | 1 |
| Abd Elmageed, ZY; Abdel-Mageed, AB; Gur, S; Hellstrom, WJ; Kadowitz, PJ; Pankey, E; Rezk, B; Sikka, SC | 1 |
2 other study(ies) available for tetraethylammonium and imatinib mesylate
| Article | Year |
|---|---|
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells.
Topics: Adrenergic alpha-Antagonists; Benzamides; Drug Therapy, Combination; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Octamer Transcription Factor-1; Piperazines; Prazosin; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Tetraethylammonium; Tumor Cells, Cultured | 2010 |
Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new RTK targets.
Topics: Adult; Aged; Apamin; Benzamides; Enzyme Activation; Erectile Dysfunction; Humans; Imatinib Mesylate; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Oxadiazoles; Penis; Phosphorylation; Piperazines; Potassium Channel Blockers; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Quinoxalines; Receptor Protein-Tyrosine Kinases; Tetraethylammonium | 2013 |